Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Study paves way for effective monitoring of chemotherapeutic drug level in cancer patients

Study paves way for effective monitoring of chemotherapeutic drug level in cancer patients

New machine learning algorithm ranks drugs based on efficacy in reducing cancer cell growth

New machine learning algorithm ranks drugs based on efficacy in reducing cancer cell growth

Near-infrared hyperspectral imaging technique can facilitate the diagnosis of fatty liver diseases

Near-infrared hyperspectral imaging technique can facilitate the diagnosis of fatty liver diseases

Auto-aggressive immune cells cause liver immune pathology in non-alcoholic steatohepatitis

Auto-aggressive immune cells cause liver immune pathology in non-alcoholic steatohepatitis

New technique traces genetic and epigenetic origins of DNA to reveal hidden cancers

New technique traces genetic and epigenetic origins of DNA to reveal hidden cancers

$11 million COBRE funding will help create Center for Pre-Clinical Cancer Research at LSU SVM

$11 million COBRE funding will help create Center for Pre-Clinical Cancer Research at LSU SVM

Scientists discover how novel pathogens promote colorectal cancer development

Scientists discover how novel pathogens promote colorectal cancer development

Princeton researchers elucidate how hepatitis B virus establishes chronic infection

Princeton researchers elucidate how hepatitis B virus establishes chronic infection

New study aims to improve anti-cancer drug response predictions across cancer types

New study aims to improve anti-cancer drug response predictions across cancer types

Researchers identify cells responsible for maintenance and regeneration of liver

Researchers identify cells responsible for maintenance and regeneration of liver

Current screening guidelines may not detect liver cancer soon enough in African Americans

Current screening guidelines may not detect liver cancer soon enough in African Americans

Study shows how m6A regulators influence metabolic heterogeneity of hepatocellular carcinoma

Study shows how m6A regulators influence metabolic heterogeneity of hepatocellular carcinoma

Researchers urge European policymakers to make adequate resources available to tackle pancreatic cancer

Researchers urge European policymakers to make adequate resources available to tackle pancreatic cancer

Scientists discover new immunotherapy target for malignant brain tumors

Scientists discover new immunotherapy target for malignant brain tumors

Ionic liquid formulation kills cancer cells, allows uniform distribution of chemotherapy to tumors

Ionic liquid formulation kills cancer cells, allows uniform distribution of chemotherapy to tumors

Pandemic-fueled alcohol abuse creates wave of hospitalizations for liver disease

Pandemic-fueled alcohol abuse creates wave of hospitalizations for liver disease

GLS1 inhibitor selectively eliminates senescent cells, ameliorates age-associated disorders

GLS1 inhibitor selectively eliminates senescent cells, ameliorates age-associated disorders

New combination therapy proven to be highly effective in HBV infection model

New combination therapy proven to be highly effective in HBV infection model

Gut microbiome can modulate the immune response in liver cancer patients with NAFLD

Gut microbiome can modulate the immune response in liver cancer patients with NAFLD

Researchers design armored immune cells to attack recurring cancer in liver transplant patients

Researchers design armored immune cells to attack recurring cancer in liver transplant patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.